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Objective: The early identification of the onset of subclinical atheromatosis is essential in reducing the high mortality
risk from cardiovascular disease (CVD) worldwide. Although carotid intima-media thickness (cIMT) is the most commonly
used early predictor of ongoing atherosclerosis, an experimental model of atherosclerosis, demonstrated that increases
in adventitial microvessels (vasa vasorum (VV)) precede endothelial dysfunction. Using the reported accuracy of
contrast-enhanced ultrasound (CEU) to measure carotid adventitial VV, this study assessed whether measurements of
carotid adventitial VV serve as a marker of subclinical atherosclerotic lesions in a control population with none of the
classical risk factors for CVD.
Methods and results: Measurements of cIMT (B-mode ultrasound) and adventitial VV (CEU) were conducted in 65
subjects, 30–70 years old, 48% men, with none of the classical risk factors for CVD. Adventitial VV strongly correlated with
its own cIMT only in the left carotid artery. Importantly, the left carotid adventitial VV directly correlated with age.
Conclusions: The increases with age in left carotid adventitial VV in individuals with zero risk for atheromatosis suggest
that the measurement of carotid adventitial VV could be an accurate and sensitive marker for the diagnosis of subclinical
atheromatosis and therefore a prominent tool for monitoring the efficacy of anti-atheromatous therapies.
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Atherosclerosis is the leading cause of death in the gen-
eral population worldwide [1]. The ability to identify the
atherosclerotic process at early stages is of great value
for attenuating the risk of adverse cardiovascular disease
(CVD) events.
At present, carotid intima-media thickness (cIMT) is
the earliest and most widely used predictor of atheroma-
tosis. Indeed, not only is cIMT associated with several
traditional risk factors including smoking, high choles-
terol, high blood pressure, and high glucose [2,3], but* Correspondence: arcivicki@hotmail.com
1Department of Nephrology, Hospital Universitari Arnau de Vilanova, Avda
Rovira Roure, 80, 25198 Lleida, Spain
2Unitat de Detecció i Tractament de Malalties Aterotrombòtiques, Hospital
Universitari Arnau de Vilanova, Avda Rovira Roure, 80, 25198 Lleida, Spain
Full list of author information is available at the end of the article
© 2015 Arcidiacono et al.; licensee BioMed Ce
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.more significantly, cIMT improves the prognostic risk
prediction of either one or more than one of any of
these traditional risk factors, particularly in women [4].
Importantly, ultrasonographic measurements provide an
accurate estimation of cIMT. To this point, Pignoli et al.
find no significant differences between the ultrasono-
graphic measurements of the IMT in the common
carotid arteries and those determined histologically [5].
Important for the identification of the pathophysiology
underlying cIMT was the immunohistochemical analysis
of human carotid atherosclerotic lesions. At pre-atheroma
stages, microvessels originating from the adventitial layer
are present in the intima layer, while they are absent in the
normal intima and also in atheromatous lesions that are
independent of intimal thickening [6,7]. These microves-
sels are known as vasa vasorum (VV), and they arentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nourishment to medium and large vessels including aorta,
coronary, femoral, and carotid arteries. Experimental evi-
dence supports a role of the neoangiogenesis originating
from the adventitial layer in the initiation and progression
of the atherosclerotic process [8]. This initial demonstra-
tion that hypercholesterolemia increases adventitial VV
before the development of atherosclerotic lesion in
porcine coronary arteries is further supported by the stud-
ies by Herrmann et al., using three-dimensional micro-
computed tomography (CT) [9]. In the coronary arteries of
pigs fed a hypercolesterolemic diet, the marked increases in
the density of adventitial VV precede endothelial dysfunc-
tion, the first alteration leading to atherosclerosis [9]. These
experimental findings suggest that imaging VV in the ad-
ventitia in vivo could identify stages in the development of
atherosclerosis prior to the well-recognized increases in
cIMT, thus favoring an early identification of patients with
a higher risk of cerebrovascular events.
Contrast-enhanced ultrasound (CEU) has been intro-
duced as a useful, non-invasive and inexpensive tech-
nique for studying VV in the carotid arteries [10].
Indeed, several studies have identified plaque neovascular-
ization using CEU, which were histologically confirmed
after endarterectomy [11-13]. However, these studies were
prevalently focused on intraplaque neovascularization. In
order to use the degree of neovascularization necessary for
CEU assessment to predict cerebrovascular risk, a better
understanding of the physiological/pathological amount of
VV in the carotid adventitial layer was necessary. Indeed,
the first report of an increase of the periadventitial VV
network in patients with carotid stenosis of at least >50%,
compared with that in patients with no carotid stenosis,
utilized a combination of sonographic contrast agent and
B-flow images [14]. More recently, the direct in vivo
visualization of the adventitial neovascularization by CEU
has been reported: values from type 2 diabetic patients
showed a higher adventitial vascularization in comparison
with the values from healthy subjects. Furthermore,
diabetic patients affected by retinopathy showed a higher
adventitial VV than did patients not affected by retinop-
athy [15].
Therefore, the aim of the study was to study a group
of healthy volunteers with none of the classical risk fac-
tors for CVD (smoking, hypertension, hypercholesterol-
emia, diabetes) to assess the physiological density of
adventitial VV.
Materials and methods
Study subjects
Subjects with none of the classical risk factors for car-
diovascular disease were enrolled to obtain a physio-
logical estimate of adventitial VV content prior to the
development of atheromatosis. All of the 65 enrolledsubjects were non-smokers, and with morphometric and
biochemical parameters within the normal range. The
age range was between 30 and 70 years, and 48% were
men. During enrollment, some subjects were excluded
for the following reasons: 1) They met the exclusion cri-
teria for the administration of the contrast agent includ-
ing: a) recent cardiac instability, b) recent (<7 days)
coronary intervention, c) class III or IV heart failure, d)
severe pulmonary hypertension, or e) allergic reaction to
sulphur hexafluoride, the main component of the con-
trast agent; 2) The detection of a carotid plaque during
B-mode ultrasound. This protocol was approved by the
ethical committee at the University Hospital Arnau de
Vilanova (HUAV, Lleida, Spain). After being informed
of the goals and protocols, all subjects signed con-
sents before morphometric parameter acquisition and
the drawing of blood.
Morphometric and biochemical parameters
Morphometric parameters were obtained by standard
methods. Briefly, weight and height were measured with
a digital weight scale with a stadiometer. Body mass
index (BMI) was then calculated as weight in kilograms
divided by the square of height in meters. The waist cir-
cumference (WC) was measured in centimeters at the
umbilicus level. Blood pressure (BP) was measured as
the average of triplicate values obtained with an auto-
mated oscillometer (Omron HEM-705CP) while patients
were seated and had rested for ten minutes. Pulse
pressure (PP) was calculated as the difference between
mean systolic (SBP) and mean diastolic blood pressure
(DBP). Biochemical parameters (glucose, total choles-
terol (Cholesterol), HDL and LDL cholesterol, and tri-
glycerides (TG)) were obtained after overnight fasting
using the standard methods of the laboratory of Clinical
Biochemistry at the HUAV. Ultrasensitive C-reactive
protein (CRP) was measured in the same laboratory
using an immunoturbidimetric assay (Roche Diagnostic
on a Hitachi automated analyzer).
Standard and contrast-enhanced carotid ultrasound
All subjects (supine position) underwent a B-mode ultra-
sound examination of the extra-cranial carotid arteries
including the common, bulb, internal, and the external
carotid artery (CA). A prior axial exploration was
followed by a longitudinal exploration for the evaluation
of atheromatous plaque presence and for measurements
of cIMT of the far wall of the common artery. The cIMT
was calculated as the gray-scale layer comprised within
the luminal blood and the carotid adventitia layer at the
level of 1 cm proximal to the bifurcation. Two independ-
ent readers (MVA, TV) read cIMT and reproducibility, ac-
cording to the obtained intraclass correlation coefficient
(ICC) of 0.822 (range 0.745-0.877), was classified as good
Table 1 Baseline characteristics of the study population
Female (n = 34) Male (n = 31) p-value
Age (years) 50 ± 10 48 ± 11 0.626
Glucose (mg/dl) 91.7 ± 10 93.9 ± 7 0.092
Cholesterol (mg/dl) 177.3 ± 26 181.4 ± 27 0.275
HDL-Cholesterol (mg/dl) 58.8 ± 11 49.1 ± 12 0.003
LDL- Cholesterol (mg/dl)* 106.3 (94–120) 122.6 (97–136) 0.032
TG (mg/dl)* 56.0 (48–68) 65.0 (47–90) 0.205
CRP (mg/l)* 0.8 (0.5-1.7) 0.8 (0.5-2.3) 0.568
SBP (mmHg) 120.3 ± 14 124.4 ± 11 0.106
DBP (mmHg) 74.5 ± 8 74.9 ± 8 0.989
PP (mmHg) 45.8 ± 10 48.6 ± 9 0.264
WC (cm) 85.7 ± 10 91.9 ± 8 0.009
BMI (Kg/m2) 24.8 ± 4 25.2 ± 2 0.290
*Identified variables with non-normal distribution. Values of these variables
are described with Median (IQR). For variables with no significant deviations
from normal distribution, values are provided as mean ± standard deviation.
Mann–Whitney test p-values to test differences between females and males
are provided given the small sample size. Statistically significant p-values are
indicated in bold.
TG: triglycerides; CRP: C-reactive protein; SBP: systolic blood pressure;
DBP: diastolic blood pressure; PP: pulse pressure; WC: waist circumference;
BMI: body mass index.
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aging procedure using the contrast agent Sonovue (Bracco
Spa, Milan, Italy), a phospholipidic shell containing sulfure
hexafluoride. A Sonovue vial was solubilized in 5 ml of sa-
line, and a 2.5 ml bolus was injected first, followed by
10 ml of a saline flush, in the antecubital vein for each CA
explored (20-gauge needle to avoid microbubbles rupture).
According to the manufacturer’s information, the contrast
agent has no adverse effects at this dose and was sufficient
to obtain a strong and clear signal for a 1-minute image
recording. The CEU imaging was performed with a
Siemens Sequoia 512 using the 15L8W linear array probe
(7 Mhz) with a low mechanical index of 0.18. The Sequoia
512 is equipped with Cadence contrast Pulse Sequencing
(CPS) technology able to combine the nonlinear funda-
mental and higher harmonic nonlinear fundamental con-
trast signals determining a high sensitivity and specificity
of contrast agent detection. During imaging acquirement
it is possible to specifically separate “tissue only”, “contrast
agent only” or “both together”, specifically we worked on
“CA” methodology that means “contrast agent only”. All
the videos were stored for a posterior reading using the
Siemens software Syngo. As previously described [15],
adventitial VV content in the far adventitial layer was cal-
culated as the average of the ratios of the intensities in the
2 mm above the intima-lumen boundary and the inten-
sities of the 2 mm below the media-adventitia boundary of
the common carotid artery 1 cm proximal to the bifur-
cation. The final result (VV signal) was calculated as the
average of 10 to 20 ratios calculated for each diastolic
frame in which both the lumen intensity and the adventi-
tial intensity was high and stable within a 1 minute video
recording. As reported [15], the intraobserver variability
was classified as very good (CCI = 0.930; 0.84-0.970);
while, the reproducibility of the method, calculated on two
readers (AMV, RE), was classified as good (ICC = 0.870;
0.780-0.920), comparable to the reproducibility of cIMT
measurements. As reported in [16] we excluded from
reading videos in which signals were observed in the far
arterial wall before contrast injection therefore avoiding
artefact images. Additional reasons for reading exclusion
were: 1) the contrast agent disappeared rapidly thus im-
peding to be properly visualized; or 2) the presence of an
ultrasound shadow in the area of the carotid under ana-
lysis that impeded the reading.
Statistical analysis
Data analysis was performed by an investigator totally
blinded to the characteristics of the patients. The SPSS
v17 software was used for analysis. Morphometric and
biochemical values, as well as cIMT and VV ratio, were
expressed as mean ± standard deviation if there was no
significant deviation from normal distribution, or as me-
dian (interquartile rage) if non-normal distribution wasobserved. Normal distribution was analyzed using the
Kolmogorov-Smirnov test. The Mann–Whitney test ex-
amined the statistical difference of the parameters in the
two genders. The Spearman’s rank correlation coeffi-
cients assessed the correlation between the adventitial
VV ratio and the cIMT and between the VV ratio and the
biochemical or anthropometric parameters. Statistical
significance was defined as p < 0.05.
Results
Subject characteristics, stratified by gender, are shown in
Table 1. According to the inclusion criteria, age distribution
was similar between women (50 ± 10) and men (48 ± 11),
and all examined parameters were within the normal
physiological range. Gender differences were observed for
serum HDL and LDL levels (women: 58.8 ± 11 vs men:
49.1 ± 12, p = 0.003, and women: 106.3(94–120) vs men:
122.6(97–136), p = 0.032, respectively), and, as expected,
the waist circumference (WC) was lower in women than in
men (85.7 ± 10 vs 91.9 ± 8, p = 0.009, respectively).
Ultrasound measurements of cIMT and of adventitial
vasa vasorum (VV) content are shown in Table 2. As
shown in panel A, the mean cIMT value of the common
CA was 0.646 ± 0.107, and no difference was observed
between women and men (0.636 ± 0.107 vs 0.656 ± 0.108).
The mean VV ratio (panel B) was 0.577 ± 0.119 and there
was no difference in VV ratio between women and men
(0.560 ± 0.104 vs 0.594 ± 0.133). In addition, there were no
statistical differences between cIMT and VV ratio in the
right and the left CA of both, women and men.
Table 2 cIMT and carotid adventitial VV values
A
cIMT (mm) Right cIMT (mm) Left cIMT (mm)
Female 0.636 ± 0.107 0.626 ± 0.102 0.646 ± 0.130
Male 0.656 ± 0.108 0.641 ± 0.127 0.671 ± 0.127
Females vs. Males* 0.340 0.608 0.412
Total 0.646 ± 0.107 0.633 ± 0.114 0.658 ± 0.128
B
VV (ratio) Right VV (ratio) Left VV (ratio)
Female 0.560 ± 0.104 0.568 ± 0.130 0.544 ± 0.146
Male 0.594 ± 0.133 0.598 ± 0.208 0.596 ± 0.144
Females vs. Males* 0.162 0.403 0.270
Total 0.577 ± 0.119 0.582 ± 0.171 0.573 ± 0.146
Values are expressed as mean ± standard deviation after confirming no
significant deviation from the normal distribution. (*) Mann–Whitney test
p-values to test differences between females and males are provided given
the small sample size.
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between the average left and right cIMT and the average
left and right of adventitial VV ratio of all 65 subjects.
Interestingly, although no correlation was observed be-
tween the right cIMT and the right carotid adventitial
VV (r = 0.125, Figure 1 panel C), the left cIMT signifi-
cantly correlated with the left carotid adventitial VV
(r = 0.370, p = 0.004, Figure 1 panel B).Figure 1 cIMT correlates directly with adventitial VV only in the left carotid
adventitial VV. Panels B and C. Left and right values of cIMT and adventitia
defined as p < 0.05.Moreover, as shown in Table 3, only age correlated
with the left VV ratio (r = 0.313, p = 0.015). None of the
biochemical or anthropometric parameters examined
correlated with the adventitial VV ratio, including when
separately considering the right and the left CA.
Discussion
This study in healthy individuals with no classical risk
factors for atheromatosis, in which exclusively the left
carotid adventitial VV density correlated with both age
and left cIMT, supports the accuracy and sensitivity of
measurements of the left carotid adventitial VV density
as an early marker of subclinical atheromatosis.
Indeed, using a population without clinical atheroma-
tosis and with none of the classical risk factors for the
development of atheromatous disease, a statistical sig-
nificant correlation between the left cIMT and the left
VV ratio was observed (r = 0.370; p = 0.004). No correl-
ation was observed in the right side, or when consider-
ing the VV ratio and the cIMT as the average of the
values of the left and the right carotid arteries. The latter
finding is similar to that reported by Sampson et al. in
patients with minimal atherosclerosis, which demon-
strates no association between cIMT and adventitial VV
when considering the average of both CA (left and right)
[17]. Therefore, the results of the current study highlight
the importance of examining the left and the right CA
independently in patients not affected by atheromatosis.artery. Panel A. Average of left and right values for cIMT and
l VV. r = Spearman’s correlation coefficient. Statistical significance is
Table 3 Correlation between carotid adventitial VV ratio
and the biochemical or anthropometric parameters
Right VV Ratio Left VV Ratio
Age (years) −0.079 (0.563) 0.313 (0.015)*
Glucose (mg/dl) −0.129 (0.344) −0.150 (0.252)
Cholesterol (mg/dl) 0.135 (0.321) −0.144 (0.272)
HDL-Cholesterol (mg/dl) 0.037 (0.787) 0.035 (0.789)
LDL-Cholesterol (mg/dl) 0.063 (0.643) −0.083 (0.530)
TG (mg/dl) 0.147 (0.281) −0.139 (0.291)
CRP (mg/l) 0.026 (0.850) −0.188 (0.150)
SBP (mmHg) −0.007 (0.961) 0.115 (0.383)
DBP (mmHg) 0.042 (0.762) 0.038 (0.773)
PP (mmHg) −0.079 (0.566) 0.138 (0.296)
WC (cm) 0.172 (0.228) 0.038 (0.785)
BMI (kg/m2) 0.018 (0.891) −0.074 (0.593)
Spearman’s correlation coefficient (p-value). (*) p < 0.05.
TG: triglycerides; CRP: C-reactive protein; SBP: systolic blood pressure;
DBP: diastolic blood pressure; PP: pulse pressure; WC: waist circumference;
BMI: body mass index.
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contribution of increases in neovascularization (vasa
vasorum) to plaque instability [18]. Furthermore, the few
post-mortem studies in humans showing increases in
VV in the plaque are insufficient to support the contri-
bution of increases in adventitial VV to initiate the ath-
erosclerotic process that was observed in experimental
hypercholesterolemic settings [9]. The direct correlation
between the left VV ratio and the left cIMT demon-
strated herein, and our recent demonstration that,
despite similar values of cIMT, diabetic patients with
retinopathy (angiogenesis) presented a higher carotid
adventitial VV ratio [15] support the experimental
findings in which increases in adventitial VV precede
the increases in cIMT [9].
The decision to distinguish between the VV density in
left and right CAs was based upon Lemne’s findings of
higher values of the cIMT on the left CA in normoten-
sive individuals [19] and more importantly, by the fact
that the association between cardiovascular risk and vas-
cular anatomy is not uniform for the thickness of
intima-media layer [20] or for the presence of plaque
[21,22]. Furthermore, this anatomical difference is atten-
uated with the occurrence of atherosclerotic risk factors
such as hypertension. Indeed, subjects with mean blood
pressure of 90 mmHg (or lower) had a higher cIMT in
the left than in the right CA, while, when mean arterial
blood pressure was higher than 90 mmHg, not only did
age not affect cIMT, but also the differences in wall
thickening between the left and the right CA attenuated
[23]. These findings are in line with the Rotterdam
Study in which, in a population aged 55 or over, the
differences between participants with and withouthypertension are significant only in the right CA,
therefore suggesting the possibility that atherosclerotic
lesions develop in the left side earlier than in the
right side [24]. A potential explanation for this differ-
ence is that the left CA originates directly from the
aortic arch and is therefore exposed to a constantly
higher shear stress [25]. The fact that atherosclerotic
lesions appear earlier in the left than in the right CA
could in part explain our finding of a correlation
between the adventitial VV and the cIMT only in the
left CA.
None of the measured biochemical or anthropometric
parameters, all of which are highly involved in the devel-
opment of atheromatous disorders, except for age corre-
lated with adventitial VV ratio. Since aging is the natural
determinant of a higher prevalence of atheromatous
lesions in otherwise healthy individuals, our demonstra-
tion of no association of the right adventitial VV with
age supports the high sensitivity of CEU measurements
of left adventitial VV density for the diagnosis of sub-
clinical atheromatosis.
A limitation of the present study is the small number
of enrolled patients due to the strict inclusion criteria.
Furthermore the strong direct correlation between age
and left adventitial VV in this population with zero risk
for atheromatosis, underscores the need to conduct a
study with similar inclusion criteria but with the ap-
propriate statistical power to obtain reference values
of VV density in the left and right carotids within a
gender and also at different ranges of age. Importantly, the
present study provides the mandatory data to infer
the appropriate sample size to accurately establish
physiological values of adventitial VV density. This is
a mandatory first step to evaluate the abnormalities in
adventitial VV in patients at a higher risk for cardiovascu-
lar disease.Conclusions
In conclusion, our findings suggest that CEU measure-
ments of carotid adventitial VV provide a novel marker
to explore the atheromatous development process and
in monitoring disease progression and the response to
anti-atheromatous strategies. Additional studies in popula-
tions considered at a higher CV risk, including smokers or
individuals with hypertension, hypercholesterolemia, dia-
betes, or renal disease are needed to further explore the
distinct contribution of increases in left or right adventitial
VV ratio to the progression of the atheromatous process
and to its regression in response to anti-atheromatous
therapies.Competing interests
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